Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC |
Bruneau AureGroup President
|
Exercise / conversionCommon Stock | 2,780 | $114.44 | $318,143.20 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 9 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC |
Bruneau AureGroup President
|
SaleCommon Stock | 2,910 | $141.17 | $410,798.88 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 8 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757 F4 · price: Represents the sale of 2,910 shares in multiple transactions ranging in price from $141.065 to $141.505 per share, resulting in a weighted average sale price of $141.168. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC |
Bruneau AureGroup President
|
Exercise / conversionCommon Stock | 2,910 | $121.88 | $354,670.80 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 7 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC |
Bruneau AureGroup President
|
SaleCommon Stock | 1,613 | $141.48 | $228,199.18 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 6 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757 F3 · price: Represents the sale of 1,613 shares in multiple transactions ranging in price from $141.00 to $141.72 per share, resulting in a weighted average sale price of $141.475. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC |
Bruneau AureGroup President
|
Exercise / conversionCommon Stock | 1,613 | $103.25 | $166,542.25 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 5 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC |
Bruneau AureGroup President
|
SaleCommon Stock | 4,718 | $141.24 | $666,384.47 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 4 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757 F2 · price: Represents the sale of 4,718 shares in multiple transactions ranging in price from $141.005 to $141.64 per share, resulting in a weighted average sale price of $141.243. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC |
Bruneau AureGroup President
|
Exercise / conversionCommon Stock | 4,718 | $104.01 | $490,719.18 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 3 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC |
Bruneau AureGroup President
|
SaleCommon Stock | 3,150 | $141.31 | $445,113.90 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 2 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757 F1 · price: Represents the sale of 3,150 shares in multiple transactions ranging in price from $140.98 to $141.595 per share, resulting in a weighted average sale price of $141.306. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC |
Bruneau AureGroup President
|
Exercise / conversionCommon Stock | 3,150 | $113.83 | $358,564.50 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:39 UTC |
Nichol Carrie AnnVP, Controller & CAO
|
GrantRestricted Stock Units · Derivative | 655 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000182 · edgar.xml · derivative · entry 2 Nichol Carrie Ann · CIK 0001735952 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655 Underlying: Common Stock · 655 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on October 1, 2020. F1 · derivative.expiration_date: Vests annually over four years in increments of 25% each year, commencing on October 1, 2020. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:39 UTC |
Nichol Carrie AnnVP, Controller & CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,840 | $0.00 Strike: $136.02 | $0.00 |
DisclosureSEC source: 0000911916-19-000182 · edgar.xml · derivative · entry 1 Nichol Carrie Ann · CIK 0001735952 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,840 Underlying: Common Stock · 2,840 shares Expires 2029-10-01 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on October 1, 2020. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:38 UTC |
Jafry Syed A.Director
|
GrantPhantom Stock Units · Derivative | 87.233 | $0.00 Strike: $136.13 | $0.00 |
DisclosureSEC source: 0000911916-19-000175 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990.402 Underlying: Common Stock · 87.233 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 1.421 phantom stock units accrued on July 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 202.013 | $0.00 Strike: $136.13 | $0.00 |
DisclosureSEC source: 0000911916-19-000168 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,510.636 Underlying: Common Stock · 202.013 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 17.865 phantom stock units accrued on July 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:36 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 202.013 | $0.00 Strike: $136.13 | $0.00 |
DisclosureSEC source: 0000911916-19-000173 · edgar.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,921.96 Underlying: Common Stock · 202.013 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 41.653 phantom stock units accrued on July 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:36 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 211.196 | $0.00 Strike: $136.13 | $0.00 |
DisclosureSEC source: 0000911916-19-000172 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,312.346 Underlying: Common Stock · 211.196 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 33.441 phantom stock units accrued on July 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:38 UTC |
MICHELSON MICHAEL WDirector
|
GrantPhantom Stock Units · Derivative | 174.466 | $0.00 Strike: $136.13 | $0.00 |
DisclosureSEC source: 0000911916-19-000176 · edgar.xml · derivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,811.471 Underlying: Common Stock · 174.466 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 9.636 phantom stock units accrued on July 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:37 UTC |
Hilado Maria TeresaDirector
|
GrantPhantom Stock Units · Derivative | 174.466 | $0.00 Strike: $136.13 | $0.00 |
DisclosureSEC source: 0000911916-19-000174 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,479.913 Underlying: Common Stock · 174.466 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 87.233 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 87.233 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 1.953 phantom stock units accrued on July 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:35 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 174.466 | $0.00 Strike: $136.13 | $0.00 |
DisclosureSEC source: 0000911916-19-000171 · edgar.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,752.541 Underlying: Common Stock · 174.466 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 11.305 phantom stock units accrued on July 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:34 UTC |
BOUDREAUX GAILDirector
|
GrantPhantom Stock Units · Derivative | 174.466 | $0.00 Strike: $136.13 | $0.00 |
DisclosureSEC source: 0000911916-19-000170 · edgar.xml · derivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,885.521 Underlying: Common Stock · 174.466 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 16.862 phantom stock units accrued on July 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:34 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 202.013 | $0.00 Strike: $136.13 | $0.00 |
DisclosureSEC source: 0000911916-19-000169 · edgar.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,751.113 Underlying: Common Stock · 202.013 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 20.065 phantom stock units accrued on July 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 09, 2019 Filed Sep 10, 2019 20:30 UTC |
Deltort DidierPresident, EMEA
|
SaleCommon Stock | 84 | $140.42 | $11,795.28 |
DisclosureSEC source: 0000911916-19-000166 · edgar.xml · nonDerivative · entry 2 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,110 F1 · shares: Securities sold to cover taxes associated with the vesting of restricted stock units on September 4, 2019, which vesting was previously reported by the reporting person. Read SEC document |
| September 06, 2019 Filed Sep 10, 2019 20:30 UTC |
Deltort DidierPresident, EMEA
|
SaleCommon Stock | 360 | $139.25 | $50,130.00 |
DisclosureSEC source: 0000911916-19-000166 · edgar.xml · nonDerivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,194 F1 · shares: Securities sold to cover taxes associated with the vesting of restricted stock units on September 4, 2019, which vesting was previously reported by the reporting person. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 20:31 UTC |
Deltort DidierPresident, EMEA
|
Exercise / conversionRestricted Stock Units · Derivative | 1,554 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000164 · edgar.xml · derivative · entry 2 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,662 Underlying: Common Stock · 1,554 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: The RSUs vest as follows: 1,554 vested on September 4, 2019; and of the remaining 4,662 RSUs, 1,554 are scheduled to vest on each of September 4, 2020, September 4, 2021 and September 4, 2022. F2 · derivative.expiration_date: The RSUs vest as follows: 1,554 vested on September 4, 2019; and of the remaining 4,662 RSUs, 1,554 are scheduled to vest on each of September 4, 2020, September 4, 2021 and September 4, 2022. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 20:31 UTC |
Deltort DidierPresident, EMEA
|
Exercise / conversionCommon Stock | 1,554 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000164 · edgar.xml · nonDerivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 20:35 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
SaleCommon Stock | 7,000 | $138.28 | $967,932.00 |
DisclosureSEC source: 0000911916-19-000162 · edgar.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,722 F1 · price: Represents the sale of 7,000 shares in multiple sale transactions, ranging in price from $138.267 to $138.352 per share, resulting in a weighted average sale price of $138.276. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 20:19 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 32,800 | $0.00 Strike: $58.02 | $0.00 |
DisclosureSEC source: 0000911916-19-000160 · edgar.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,800 shares Expires 2020-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vested annually over four years in increments of 25% each year, commencing on March 16, 2011. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 20:19 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
SaleCommon Stock | 32,800 | $140.00 | $4,592,000.00 |
DisclosureSEC source: 0000911916-19-000160 · edgar.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,722 Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 20:19 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionCommon Stock | 32,800 | $58.02 | $1,903,056.00 |
DisclosureSEC source: 0000911916-19-000160 · edgar.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 249 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan and pursuant to dividend reinvestement between April 26, 2019 and July 29, 2019. Read SEC document |
| August 08, 2019 Filed Aug 9, 2019 20:15 UTC |
Yi SangPresident, Asia Pacific
|
SaleCommon Stock | 147 | $138.70 | $20,388.17 |
DisclosureSEC source: 0000911916-19-000158 · edgar.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,457 F1 · balance_after: Includes 147 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan on June 28, 2019. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 20:12 UTC |
Upadhyay SuketuExec. VP, CFO
|
GrantRestricted Stock Units · Derivative | 14,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000151 · edgar.xml · derivative · entry 2 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,620 Underlying: Common Stock · 14,620 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on July 1, 2020. F1 · derivative.expiration_date: Vests annually over four years in increments of 25% each year, commencing on July 1, 2020. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 20:12 UTC |
Upadhyay SuketuExec. VP, CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 63,510 | $0.00 Strike: $117.80 | $0.00 |
DisclosureSEC source: 0000911916-19-000151 · edgar.xml · derivative · entry 1 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,510 Underlying: Common Stock · 63,510 shares Expires 2029-07-01 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on July 1, 2020. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:17 UTC |
BOUDREAUX GAILDirector
|
GrantPhantom Stock Units · Derivative | 204.161 | $0.00 Strike: $116.33 | $0.00 |
DisclosureSEC source: 0000911916-19-000146 · edgar.xml · derivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,694.193 Underlying: Common Stock · 204.161 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:18 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 236.397 | $0.00 Strike: $116.33 | $0.00 |
DisclosureSEC source: 0000911916-19-000148 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,290.758 Underlying: Common Stock · 236.397 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: This amount reflects the deduction of 98.551 units to correct an error in the reporting person's Forms 4 filed on April 2, 2019 and May 14, 2019, in which the number of phantom stock units received by the reporting person on March 31, 2019, and the total number of phantom stock units held by the reporting person following that date, were over-reported by 98.551 units. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:17 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 236.397 | $0.00 Strike: $116.33 | $0.00 |
DisclosureSEC source: 0000911916-19-000147 · edgar.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,529.035 Underlying: Common Stock · 236.397 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:17 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 204.161 | $0.00 Strike: $116.33 | $0.00 |
DisclosureSEC source: 0000911916-19-000145 · edgar.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,566.77 Underlying: Common Stock · 204.161 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:16 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 236.397 | $0.00 Strike: $116.33 | $0.00 |
DisclosureSEC source: 0000911916-19-000143 · edgar.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,678.294 Underlying: Common Stock · 236.397 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:16 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 247.142 | $0.00 Strike: $116.33 | $0.00 |
DisclosureSEC source: 0000911916-19-000144 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,067.709 Underlying: Common Stock · 247.142 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:15 UTC |
Hilado Maria TeresaDirector
|
GrantPhantom Stock Units · Derivative | 204.161 | $0.00 Strike: $116.33 | $0.00 |
DisclosureSEC source: 0000911916-19-000142 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,303.494 Underlying: Common Stock · 204.161 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 102.081 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 102.081 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:15 UTC |
Jafry Syed A.Director
|
GrantPhantom Stock Units · Derivative | 102.081 | $0.00 Strike: $116.33 | $0.00 |
DisclosureSEC source: 0000911916-19-000141 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 901.748 Underlying: Common Stock · 102.081 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:14 UTC |
MICHELSON MICHAEL WDirector
|
GrantPhantom Stock Units · Derivative | 204.161 | $0.00 Strike: $116.33 | $0.00 |
DisclosureSEC source: 0000911916-19-000140 · edgar.xml · derivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,627.369 Underlying: Common Stock · 204.161 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| May 24, 2019 Filed May 29, 2019 20:16 UTC |
Yi SangPresident, Asia Pacific
|
SaleCommon Stock | 426 | $114.88 | $48,938.03 |
DisclosureSEC source: 0000911916-19-000122 · edgar.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,457 Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:26 UTC |
Hilado Maria TeresaDirector
|
GrantRestricted Stock Units · Derivative | 1,078.122 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000115 · edgar.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078.122 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:26 UTC |
Hilado Maria TeresaDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.58 | $0.00 |
DisclosureSEC source: 0000911916-19-000115 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,099.333 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 0.811 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:27 UTC |
MICHELSON MICHAEL WDirector
|
GrantRestricted Stock Units · Derivative | 1,078.122 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000117 · edgar.xml · derivative · entry 2 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,417.212 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:27 UTC |
MICHELSON MICHAEL WDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.58 | $0.00 |
DisclosureSEC source: 0000911916-19-000117 · edgar.xml · derivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,423.208 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 9.308 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:27 UTC |
Jafry Syed A.Director
|
GrantRestricted Stock Units · Derivative | 1,078.122 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000116 · edgar.xml · derivative · entry 2 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078.122 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:27 UTC |
Jafry Syed A.Director
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.58 | $0.00 |
DisclosureSEC source: 0000911916-19-000116 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 799.667 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 0.405 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:25 UTC |
HIGGINS ARTHUR JDirector
|
GrantRestricted Stock Units · Derivative | 1,078.122 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000114 · edgar.xml · derivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,840.581 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:25 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.58 | $0.00 |
DisclosureSEC source: 0000911916-19-000114 · edgar.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,441.897 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 44.659 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:25 UTC |
HAGEMANN ROBERTDirector
|
GrantRestricted Stock Units · Derivative | 1,078.122 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000113 · edgar.xml · derivative · entry 2 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,399.858 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.